GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Cyclically Adjusted PB Ratio

Kolon Life Science (XKRX:102940) Cyclically Adjusted PB Ratio : (As of Sep. 21, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kolon Life Science Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kolon Life Science's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Cyclically Adjusted PB Ratio Chart

Kolon Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 1.56 2.28 1.39 1.28

Kolon Life Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 1.29 1.28 1.14 -

Competitive Comparison of Kolon Life Science's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kolon Life Science's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kolon Life Science's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kolon Life Science's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kolon Life Science's Cyclically Adjusted PB Ratio falls into.



Kolon Life Science Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kolon Life Science's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Kolon Life Science's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=10361.29/*
=

Current CPI (Jun. 2024) = .

Kolon Life Science Quarterly Data

Book Value per Share CPI Adj_Book
201409 13,199.437 99.608 0.000
201412 13,213.796 99.098 0.000
201503 13,013.203 99.720 0.000
201506 13,020.823 100.050 0.000
201509 12,981.423 100.110 0.000
201512 13,142.710 100.220 0.000
201603 13,280.119 100.560 0.000
201606 22,197.311 100.790 0.000
201609 22,407.028 101.460 0.000
201612 22,779.669 101.560 0.000
201703 22,666.079 102.850 0.000
201706 22,726.460 102.610 0.000
201709 22,645.050 103.490 0.000
201712 71,737.108 102.990 0.000
201803 45,909.771 104.100 0.000
201806 40,703.273 104.130 0.000
201809 45,479.013 105.650 0.000
201812 39,134.911 104.350 0.000
201903 31,513.009 104.490 0.000
201906 11,205.886 104.880 0.000
201909 10,357.608 105.200 0.000
201912 8,861.286 105.120 0.000
202003 8,602.297 105.540 0.000
202006 8,173.992 104.870 0.000
202009 8,458.408 106.200 0.000
202012 5,083.870 105.765 0.000
202103 5,068.666 107.357 0.000
202106 5,635.941 107.579 0.000
202109 5,767.409 108.759 0.000
202112 8,720.036 109.676 0.000
202203 8,488.744 111.806 0.000
202206 8,930.462 114.083 0.000
202209 8,968.629 114.831 0.000
202212 14,696.580 115.200 0.000
202303 14,551.119 116.550 0.000
202306 14,163.861 117.140 0.000
202309 13,200.761 119.111 0.000
202312 12,063.368 118.848 0.000
202403 13,992.679 118.848 0.000
202406 10,361.290 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kolon Life Science  (XKRX:102940) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kolon Life Science Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kolon Life Science Business Description

Traded in Other Exchanges
N/A
Address
110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR
Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science Headlines

No Headlines